Servier Russia Deploys IMS Health’s Nexxus Mobile Intelligence CRM Solution To Drive Commercial Effectiveness
March 14 2016 - 11:01PM
Business Wire
Scalable Cloud-Based Platform Seamlessly
Supports More Productive Customer Engagement
IMS Health (NYSE:IMS) today announced that Servier Russia, a
Groupe Servier subsidiary, is deploying the Nexxus™ Mobile
Intelligence CRM solution to drive the efficiency and performance
of its sales force. Drawing from uniquely broad and diverse data
sources that include IMS Health, client and third-party
information, Nexxus MI curates insights that will enable Servier
Russia’s commercial team to create precision conversations with
customers across multiple channels for more productive
engagement.
Nexxus MI helps life sciences companies implement their national
brand strategies at local levels by connecting continuously updated
industry and company intelligence with strategic decision-support
tools. Field teams can interact with their customers using
preferred communications channels on any digital device, anytime
and anywhere. In addition, offline access to most Nexxus MI
functions benefits customer-facing teams that spend significant
time working in locations where connectivity may not be available.
Servier Russia will leverage the IMS Health scalable cloud-based
solution to execute effective commercial strategies for reaching
the right customers across the right channels with the right
messages.
“With a strong presence in Russia’s pharmaceutical market, our
goal is to continue advancing the use of innovative treatment
options throughout the country, with high efficiency,” said Yana
Rostovtseva, operational manager, Servier Russia. “IMS Health’s
Mobile Intelligence solution brings together the information and
analytics to accelerate performance at every level of our
commercial operations. It puts powerful mobile flexibility and
functionality directly into the hands of our field sales force for
maximum impact.”
Nexxus MI is part of the Nexxus Commercial Application Suite,
which brings together the most complete and fully connected set of
applications across the commercial continuum—from marketing
campaign management and social media monitoring to customer
engagement, sales operations and performance management. The
ability to easily integrate Nexxus MI with Servier Russia’s
existing systems was a key factor in the company’s decision to
select the IMS Health solution.
“We are excited to expand our partnership with Servier Russia
and support its continued success in this dynamic market,” said
Robert Chu, IMS Health senior vice president, Technology Solutions.
“Today, multinational companies increasingly are looking to make
every customer interaction an intelligent one through the best
information and technologies. IMS Health is able to help its
clients achieve that goal.”
For more information about Nexxus MI and the Nexxus Commercial
Application Suite, visit www.imshealth.com.
About IMS Health
IMS Health is a leading global information and technology
services company providing clients in the healthcare industry with
end-to-end solutions to measure and improve their performance. Our
7,500 services experts connect configurable SaaS applications to
10+ petabytes of complex healthcare data in the IMS One™ cloud
platform, delivering unique insights into diseases, treatments,
costs and outcomes. The company’s 15,000 employees blend global
consistency and local market knowledge across 100 countries to help
clients run their operations more efficiently. Customers include
pharmaceutical, consumer health and medical device manufacturers
and distributors, providers, payers, government agencies,
policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes. Additional information is available at
www.imshealth.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160314006456/en/
IMS HealthTor Constantino,
+1-484-567-6732tconstantino@us.imshealth.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jul 2023 to Jul 2024